Neoadjuvant Immune Checkpoint Inhibitors in CSCC: A Systematic Review and Meta-Analysis.
메타분석
0/5 보강
APA
Filho VOC, Noronha MM, et al. (2026). Neoadjuvant Immune Checkpoint Inhibitors in CSCC: A Systematic Review and Meta-Analysis.. Journal of cutaneous medicine and surgery, 30(2), 175-176. https://doi.org/10.1177/12034754251364847
MLA
Filho VOC, et al.. "Neoadjuvant Immune Checkpoint Inhibitors in CSCC: A Systematic Review and Meta-Analysis.." Journal of cutaneous medicine and surgery, vol. 30, no. 2, 2026, pp. 175-176.
PMID
40785640
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (4)
- BEND3 is associated with poor prognosis and treatment response in Hepatocellular Carcinoma.
- ADH1C as a robust prognostic biomarker in hepatocellular carcinoma: Evidence from a multi-cohort meta-analysis.
- Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma.
- CCT3 as a promising diagnostic and prognostic biomarker in HCC.